K. Mineura et al., INHIBITION OF METHIONINE UPTAKE BY CIS-DIAMMINEDICHLOROPLATINUM(II) IN EXPERIMENTAL BRAIN-TUMORS, International journal of cancer, 67(5), 1996, pp. 681-683
cis-diamminedichloroplatinum (II) (CDDP) has been used both alone and
in combination with other chemotherapeutics for cancer chemotherapy. A
lthough CDDP acts primarily on DNA, it can also act at the tumor-cell
membrane to inhibit methionine transport. The latter mechanism of CDDP
is reported to have an important role as a chemical modulator in enha
ncing chemotherapeutic effects of 5-fluorouracil in tumor cells. We re
port here the effects of CDDP on methionine uptake in an in vive brain
-tumor model. C6 brain-tumor cells were stereotactically inoculated in
the right basal ganglia of 6-weekold male Sprague-Dawley rats. Ten da
ys after the inoculation, autoradiographic images were obtained using
('4C-methyl)-Lmethionine. The tracer uptake, represented as differenti
al absorption ratio (DAR) and an acid-insoluble fraction (AIF), was me
asured in both brain tumors and normal brain with or without an intrav
enous injection of CDDP. The tumor/nontumor DAR and AIF decreased sign
ificantly (P < 0.01, as determined by the Mann-Whitney U-test) after C
DDP treatment, whereas the non-tumor DAR and AIF remained almost uncha
nged. These findings indicate that CDDP inhibits methionine uptake sel
ectively in brain-tumor tissue and may therefore be a potent chemical
modulator in the chemotherapy of brain tumors. (C) 1996 Wiley-Liss, In
c.